Therefore, targeting IDO1 for reducing Kyn production combined with Vit-B6 supplementation for promoting Kyn catabolism could be a viable strategy against obesity and insulin resistance in clinical settings. This evidence concerns the gene IDO1 and obesity due to melanocortin 4 receptor deficiency.